Abstract
A highly regio- and stereoselective synthesis of bispirooxindoles by 1,3-dipolar cycloaddition of in situ generated azomethine ylides from isatin and proline to different electron-deficient alkenes has been developed. The synthesis affords the desired bispiro scaffold compounds in excellent yields with high regioselectivity under mild conditions. The stereochemistry was determined by single-crystal X-ray analysis.
Keywords: azomethine ylides, bispirooxindoles, cycloaddition, stereochemistry, substituted olefins
Introduction
The development of highly efficient methods to construct spiro compounds have been a hot topic of great relevance in organic synthesis due to the pronounced biological activities of this class of compounds.[1] In particular, the spirooxindole ring systems, which widely exist in a variety of natural and unnatural products, are attractive synthetic targets.[2, 3] Recently, significant research efforts have been focused on the strategy for construction of spiro 3,3′-cyclooxindoles in medicinal and agricultural chemistry due to their unique biological activity, such as spiro 3,3′-cyclooxindoles A, B, C and D (Figure 1).[4] A variety of synthetic methods have been developed to access analogous compounds possessing the spirocyclic oxindole skeleton at the C3 position of the oxindole core.[4] Moreover, the fusion of oxindole motifs with different heterocycles or heteroatoms for the formation of diverse spirocyclic oxindoles have also attracted significant attention.[5]
Figure 1.

Examples of biologically active spirooxindole derivatives.
Among the strategies for the construction of the framework of spirooxindoles,[6] it was noticed that 1,3-dipolar cycloaddition of azomethine ylides, generated from the decarboxylative condensation of isatins with different amino acid, to various olefins represented an efficient method for the construction of spiro-fused oxindoles involving the pyrrolidine moiety (Scheme 1).[7, 8] Great efforts have been made towards the [3+2] cycloaddition of azomethine ylides generated from isatin with different olefins.[9, 10] This methodology is fascinating because it provides an efficient method to construct five-membered heterocycles. Furthermore, when the electron-deficient alkene is a trisubstituted cyclic compound, the bispiro product would be obtained. A few excellent examples have been reported for the construction of bispirooxindoles.[11] It is worth noting that Xie and Wangs group have reported the construction of spiropyrrolidine bisoxindoles via 1,3-dipolar cycloaddition reaction. However, the stereochemistry of bispirooxindoles have not yet been determined when applying cyclic amino acids.11c The reactivities of this 1,3-dipolar cycloaddition reaction to construct bispirooxindoles still need to be carefully and systematically studied, and the relative configuration of many of them still need to be resolved. In this paper, we wish to report a highly regio- and stereoselective synthesis of densely functionalized bispirooxindole analogues via a three-component 1,3-dipolar cycloaddition reaction of in situ generated azomethine ylides from isatin and proline to different electron-deficient trisubstituted cyclic olefins under mild conditions.
Scheme 1.

The reaction model of the decarboxylative condensation of isatin with different amino acid.
Results and Discussion
Initial examination was carried out using N-benzyl-protected isatin 1 a (0.1 mmol), l-proline (0.12 mmol) and (E)-ethyl 2-(1-benzyl-2-oxoindolin-3-ylidene)acetate 2 a (0.12 mmol) as the substrates in methanol at 60 °C for 2 h to determine the reaction outcome (Table 1, Entry 1). We found that the desired cycloadduct 3 a was obtained in 67 % yield with >99:1 diastereomeric ratio (d.r.). Subsequently, we attempted to optimize the reaction conditions by screening solvents, and the results are summarized in Table 1 (Entries 2–5). As depicted in Table 1, the employed solvent had a significant influence on the reaction outcome. Using acetonitrile or toluene as the solvent, the yield of desired product 3 a decreased to 51 % or 20 %, respectively (Entries 2, 3). The reaction could not take place in acetone (Entry 4). Using ethanol as the solvent, the yield of 3 a was increased to 96 % along with excellent diastereoselectivities (Entry 5). Therefore, ethanol was the most suitable solvent for this reaction. Lowering the reaction temperature to 50 °C, 40 °C, 30 °C or room temperature (20 °C), the reaction proceeded smoothly, and the yield of 3 a slightly decreased to 92 % (Table 1, Entries 6–9). The stereochemistry of 3 a were determined by X-ray analysis and the ORTEP drawing is presented in Figure 2 (CIF data are summarized in the Supporting Information).
Table 1.
Optimization of the reaction conditions of the three-component 1,3-dipolar cycloaddition
![]() | ||||
|---|---|---|---|---|
| Entry[a] | Solvent | T [oC] | d.r.[b] | Yield [%][c] |
| 1 | MeOH | 60 | >99:1 | 67 |
| 2 | Actone | 60 | – | trace |
| 3 | CH3CN | 60 | >99:1 | 51 |
| 4 | Toluene | 60 | >99:1 | 20 |
| 5 | EtOH | 60 | >99:1 | 96 |
| 6 | EtOH | 50 | >99:1 | 96 |
| 7 | EtOH | 40 | >99:1 | 92 |
| 8 | EtOH | 30 | >99:1 | 92 |
| 9 | EtOH | 20 | >99:1 | 92 |
[a] All reaction was carried out with 1 a (0.1 mmol), l-proline (0.12 mmol), 2 a (0.1 mmol) in solvent (1.0 mL) in 2 h; [b] Determined by 1H NMR spectroscopy; [c] Isolated yield.
Figure 2.

The X-ray crystal structures of 3 a and 5 g.
With the identification of the optimal reaction conditions, the generality of this three-component 1,3-dipolar cycloaddition reaction was examined using a variety of isatines 1 and isatin-derived electron-deficient alkenes 2. The results are summarized in Table 2. All reactions proceeded smoothly to give the corresponding products 3 in moderate to good yields with excellent stereoselectivities under the optimal conditions (Table 2). Good yields and excellent stereoselectivities were obtained when utilizing electron-deficient oxindole alkenes 2 b–f as the substrates because regardless of whether R3 is an electron-donating or -withdrawing substituent on the aromatic ring, the reactions proceeded smoothly to give the corresponding bispirooxindole products 3 b–f in good yields (69–90 %) with excellent stereoslectivities (single isomer) (Table 2, Entries 1–5). Meanwhile, different substituents on the aromatic ring of isatin 1 did not impact the yield of 3 significantly (Table 2, Entries 6–10). Substrates with electron-donating substituent on the aromatic ring of isatins produced 3 in moderate yields (68–73 %) upon prolonging the reaction time to 24 h (entries 6–8). The yields of 3 decreased slightly using substrates with electron-withdrawing substituents on the aromatic ring (Entries 9–10). Experiments with different protecting groups at the nitrogen atoms of 1 or 2 were also conducted. To our delight, with these different protecting groups such as allyl, methyl, 9-anthracenemethyl or without protecting group, the reactions proceeded efficiently, affording the corresponding products in 73–99 % yield with >99:1 d.r. (Entries 11–16). It should be noted that using isatin 1 k having a R1 substituent at the C4 position, the three-component 1,3-dipolar cycloaddition could not give the corresponding product, perhaps due to a steric effect (Table 2, Entry 17).
Table 2.
Substrate scope of the three-component 1,3-dipolar cycloaddition reaction of 1, l-proline and 2
![]() | ||||
|---|---|---|---|---|
| Entry[a] | 1[R1/R2] | 2[R4/R3] | d.r.[b] | 3Yield [%][c] |
| 1 | 1 a (H/Bn) | 2 b (5-CH3/Bn) | >99:1 | 3 b: 87 |
| 2 | 1 a (H/Bn) | 2 c (7-CH3/Bn) | >99:1 | 3 c:90 |
| 3 | 1 a (H/Bn) | 2 d (6-OCH3/Bn) | >99:1 | 3 d: 69 |
| 4 | 1 a (H/Bn) | 2 e (7-OCH3/Bn) | >99:1 | 3 e: 72 |
| 5 | 1 a (H/Bn) | 2 f (5-Cl/Bn) | >99:1 | 3 f: 81 |
| 6 | 1 b (5-CH3/Bn)d | 2 a (H/Bn) | >99:1 | 3 g: 72 |
| 7 | 1 c (6-CH3/Bn)d | 2 a (H/Bn) | >99:1 | 3 h: 68 |
| 8 | 1 d (7-CH3/Bn)d | 2 a (H/Bn) | >99:1 | 3 i: 73 |
| 9 | 1 e (5-F/Bn) | 2 a (H/Bn) | >99:1 | 3 j: 81 |
| 10 | 1 f (5-Br/Bn) | 2 a (H/Bn) | >99:1 | 3 k: 83 |
| 11 | 1 a (H/Bn) | 2 g (H/allyl) | >99:1 | 3 l: 89 |
| 12 | 1 a (H/Bn) | 2 h (H/H) | >99:1 | 3 m: 98 |
| 13 | 1 a (H/Bn) | 2 i (H/CH3) | >99:1 | 3 n: 87 |
| 14 | 1 g (H/CH3) | 2 a (H/Bn) | >99:1 | 3 o: 83 |
| 15 | 1 h (H/9-anthmethyl)e | 2 a (H/Bn) | >99:1 | 3 p: 85 |
| 16 | 1 i (H/allyl) | 2 j (H/allyl) | >99:1 | 3 q: 99 |
| 17 | 1 j (4-Br/Bn) | 2 a (H/Bn) | – | NR[f] |
[a] All reactions were carried out with 1 (0.1 mmol), l-proline (0.12 mmol), 2 (0.1 mmol) in ethanol at 50 °C; [b] Determined by 1H NMR analysis of crude products. [c] Isolated yield. [d] For 24 h. [e] 9-Anthmethyl=9-anthracenemethyl. [f] NR=no reaction.
Instead of 2, we next attempted to use various isatin-derived electron-deficient alkenes 4 to examine the reaction outcome. Gratefully, we found that the reactions also proceeded smoothly to give the annulation products in high yields with high diastereoselectivities. The results are summarized in Table 3. Changing the electron-withdrawing group to an acetyl group, the reaction was also tolerant to an electron-deficient or electron-rich aromatic ring of 4 a–4 e (R5=H, 6-Br, 7-Br, 5-Cl or 5-CH3) with 1 a and l-proline, providing a series of the desired products 5 a–e in 75–93 % yields with excellent diastereoselectivities (Table 3, Entries 1–5). Switching the electron-withdrawing group to benzoyl, cyano, benzyl ester or a phenyl group, the corresponding products were obtained in 80-99 % yields (Table 3, Entries 6–9). The stereochemical outcome of this cycloaddition was determined by single-crystal X-ray analysis of bispirooxindole 5 g. The ORTEP drawing is shown in Figure 2 (CIF data are summarized in the Supporting Information).
Table 3.
Substrate scope of the three-component 1,3-dipolar cycloaddition reaction of 1 a, l-proline and 4
![]() | |||
|---|---|---|---|
| Entry[a] | 4(EWG/R5/R6) | d.r.[b] | 5Yield [%][c] |
| 1 | 4 a (COCH3/H/Bn) | >99:1 | 5 a: 93 |
| 2 | 4 b (COCH3/5-CH3/Bn) | >99:1 | 5 b: 83 |
| 3 | 4 c (COCH3/6-Br/Bn) | >99:1 | 5 c: 75 |
| 4 | 4 d (COCH3/7-Br/Bn) | >99:1 | 5 d: 78 |
| 5 | 4 e (COCH3/5-Cl/Bn) | >99:1 | 5 e: 82 |
| 6 | 4 f (COPh/5-F/Bn) | >99:1 | 5 f: 99 |
| 7 | 4 g (CN/H/Bn) | >99:1 | 5 g: 91 |
| 8 | 4 h (CO2Bn/H/Bn) | >99:1 | 5 h: 84 |
| 9 | 4 i (Ph/H/H) | >99:1 | 5 i: 80 |
[a] All reaction was carried out with 1 a (0.1 mmol), l-proline (0.12 mmol), 2 a (0.1 mmol) in ethanol (1.0 mL) for 2 h; [b] Determined by crude product 1H NMR spectroscopy; [c] Isolated yield by column chromatography.
We also investigated l-pipecolic acid or sarcrosine instead of l-proline in this reaction. The desired bispiro product could be obtained in almost quantitative yield with single stereoisomer (up to 99 % yield and >19:1 d.r.), respectively (Scheme 2 A and 2 B). Enlarging the reaction scale to 5.0 mmol afforded 3 a and 5 g in 92 % and 90 % yields, respectively, under the standard conditions (Scheme 2 B).
Scheme 2.

Three-component 1,3-dipolar cycloaddition reaction A) with l-pipecolic acid, B) with sarcrosine and C) performed in large scale.
Subsequently, we applied electron-deficient alkenes 8, which have similar structural motifs as 4, in this three-component 1,3-dipolar cycloaddition reaction. The results are summarized in Scheme 3. Regardless of whether R1 or R2 is an electron-rich or electron-deficient aromatic ring, the reactions proceeded smoothly to give the [3+2] annulation products in 75–94 % yields along with >99:1 d.r. values (Scheme 3). The stereochemistries of compounds 9 have not yet been determined, since these compounds gradually decomposed during recrystallization.
Scheme 3.

Substrate scope of three-component 1,3-dipolar cycloaddition reaction of 1, l-proline and 8.
We next utilize this methodology to alkene 10 derived from piperidine and alkylidene azlactone 12. As results, the corresponding products 11 were obtained in 92 % and 67 % yields as single stereoisomer, respectively (Scheme 4 A and 4 B). The stereochemistry of bispiro compound 11 has been determined by single-crystal X-ray analysis and its ORTEP drawing is indicated in Figure 3.
Scheme 4.

[3+2] Annulation of A) olefin 10 and B) olefin 12.
Figure 3.

The X-ray crystal structure of 11.
Conclusions
In conclusion, we have synthesized a series of bispirooxindole compounds via a three-component 1,3-dipolar cycloaddition reaction with respect to a variety of different alkenes, affording the corresponding bispirooxindoles in moderate to good yields (up to >99 %) and excellent diastereoselectivities (as single isomer in most cases) under mild conditions. Current efforts focusing on the asymmetric version of this reaction and applying this methodology to synthesize biologically active products are also in progress.
Experimental Section
General procedure: Isatin 1 (0.10 mmol), l-proline (0.12 mmol) and electron-deficient olefin (0.1 mmol) were added to a reaction tube. Ethanol (1.0 mL) was added, and the resulting reaction mixture was stirred at RT for 2–48 h. The solvent was removed under reduced pressure and residue was chromatographed on silica gel (elution with petroleum ether/EtOAc=6:1–4:1) to provide the desired product or filtrated to get the product.
Ethyl 2,3-bis(1′-benzyl-spiro-3′-indolino)-hexahydro-1H-pyrrolizine-1-carboxylate (3 a): White solid (57 mg 96 %): mp: 151–152 °C; 1H NMR (400 MHz, CDCl3, TMS): δ=7.69 (d, J=8.0 Hz, 1 H), 7.58 (d, J=8.0 Hz, 1 H), 7.14–6.87 (m, 10 H), 6.69 (d, J=6.8 Hz, 2 H), 6.50 (d, J=6.8 Hz, 2 H), 6.43 (t, J=8.0 Hz, 2 H), 5.28–5.23 (m, 1 H), 5.06 (d, J=16.0 Hz, 1 H), 4.91 (d, J=16.0 Hz, 1 H), 4.48 (d, J=16.0 Hz, 1 H), 4.21 (d, J=16.0 Hz, 1 H), 3.88 (d, J=10.0 Hz, 1 H), 3.79–3.71 (m, 1 H), 3.68–3.55 (m, 2 H), 2.92 (t, J=8.4 Hz, 1 H), 2.47–2.40 (m, 1 H), 2.16–2.00 (m, 2 H), 1.94–1.88 (m, 1 H), 0.55 (t, J=8.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3): δ=177.2, 175.2, 169.9, 143.5, 142.9, 135.2, 129.6, 128.7, 128.6, 128.5, 127.7, 127.1, 127.0, 126.6, 126.4, 126.3, 122.5, 122.1, 109.0, 108.5, 77.9, 67.1, 66.6, 60.3, 57.9, 48.1, 43.8, 43.4, 29.7, 26.0, 13.4; IR (neat)
=3064, 1729, 1703, 1607, 1487, 1361, 1178, 1113, 1015, 761, 694 cm−1; MS (ESI): m/z (%): 598.4 (100) [M+H]+; HRMS: m/z [M+H]+ calcd for C38H36N3O4: 598.2708, found: 598.2700.
Spectroscopic data of the compounds shown in Tables 1–3 and Scheme 1–3, the detailed descriptions of experimental procedures and the crystal structures of 3 a, 5 g, 8 c and 11 are given in the Supporting Information. CCDC-821930 (3 a), CCDC- (5 g), CCDC- (8 c) and CCDC- (11) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.
Acknowledgments
We are grateful for financial support from Shanghai Municipal Committee of Science and Technology, China (11JC1402600), the National Basic Research Program of China ((973)-2010CB833302), and the National Natural Science Foundation of China (20472096, 21372241, 21361140350, 20672127, 21102166, 21121062, 21302203 and 20732008).
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
References
- 1a.Nicholas GM, Eckman LL, Newton GL. Bioorg. Med. Chem. 2003;11:601. doi: 10.1016/s0968-0896(02)00345-0. [DOI] [PubMed] [Google Scholar]
- 1b.Suenaga K, Araki K, Sengoku T. Org. Lett. 2001;3:527. doi: 10.1021/ol006905z. [DOI] [PubMed] [Google Scholar]
- 1c.Beyersbergen van Henegouwen WG, Fieseler RM, Rutjes FPJT, Hiemstra H. J. Org. Chem. 2000;65:8317. doi: 10.1021/jo001119t. [DOI] [PubMed] [Google Scholar]
- 1d.Ciminiello P, Dell′Aversano C, Fattorusso E, Magno S, Pansini M. J. Nat. Prod. 1999;62:590. doi: 10.1021/np9805138. [DOI] [PubMed] [Google Scholar]
- 1e.Potts BCM, Faulkner DJ, Chan JA, Simolike GC, Offen P, Hemling ME, Francis TA. J. Am. Chem. Soc. 1991;113:6321. [Google Scholar]
- 2a.Trost BM, Brennan MK. Synthesis. 2009:3003. For selected reviews, see: [Google Scholar]
- 2b.Galliford CV, Scheidt KA. Angew. Chem. 2007;119:8902. [Google Scholar]
- Angew. Chem. Int. Ed. 2007;46:8748. [Google Scholar]
- 2c.Marti C, Carreira EM. Eur. J. Org. Chem. 2003:2209. [Google Scholar]
- 2d.Ramachary DB, Chowdari NS, Barbas CF., III Angew. Chem. 2003;115:4365. doi: 10.1002/anie.200351916. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2003;42:4233. [Google Scholar]
- 2e.Enders D, Grondal C, Huttl MRM. Angew. Chem. 2007;119:1590. doi: 10.1002/anie.200603129. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2007;46:1570. [Google Scholar]
- 2f.Nicolaou KC, Chen JS. Chem. Soc. Rev. 2009;38:2993. doi: 10.1039/b903290h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3a.Bencivenni G, Wu L-Y, Mazzanti A, Giannichi B, Pesciaioli F, Song M-P, Bartoli G, Melchiorre P. Angew. Chem. 2009;121:7336. doi: 10.1002/anie.200903192. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2009;48:7200. For selected examples of recent years, see: [Google Scholar]
- 3b.Chen X-H, Wei Q, Luo S-W, Xiao H, Gong L-Z. J. Am. Chem. Soc. 2009;131:13819. doi: 10.1021/ja905302f. [DOI] [PubMed] [Google Scholar]
- 3c.Dugal-Tessier J, OBryan EA, Schroeder TBH, Cohen DT, Scheidt KA. Angew. Chem. 2012;124:5047. doi: 10.1002/anie.201201643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2012;51:4963. [Google Scholar]
- 3d.Jiang K, Jia Z-J, Chen S, Wu L, Chen Y-C. Chem. Eur. J. 2010;16:2852. doi: 10.1002/chem.200903009. [DOI] [PubMed] [Google Scholar]
- 3e.Lu C, Xiao Q, Floreancig PE. Org. Lett. 2010;12:5112. doi: 10.1021/ol102246d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3f.Shen L, Shao P, Ye S. Adv. Synth. Catal. 2011;353:1943. [Google Scholar]
- 3g.Duce S, Pesciaioli F, Gramigna L, Bernardi L, Mazzanti A, Ricc A, Bartoli G, Bencivenni G. Adv. Synth. Catal. 2011;353:860. [Google Scholar]
- 3h.Zhong F, Han X, Wang Y, Lu Y. Angew. Chem. 2011;123:7983. [Google Scholar]
- Angew. Chem. Int. Ed. 2011;50:7837. [Google Scholar]
- 3i.Tan B, Candeias RN, Barbas CF., III J. Am. Chem. Soc. 2011;133:4672. doi: 10.1021/ja110147w. [DOI] [PubMed] [Google Scholar]
- 3j.Kato S, Yoshino T, Shibasaki M, Kanai M, Matsunaga S. Angew. Chem. 2012;124:7113. doi: 10.1002/anie.201203005. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2012;51:7007. [Google Scholar]
- 3k.Jia Z, Jiang H, Li J, Gschwend B, Li Q, Yin X, Grouleff J, Jørgensen KA. J. Am. Chem. Soc. 2011;133:5053. doi: 10.1021/ja1112194. [DOI] [PubMed] [Google Scholar]
- 4a.Ali MA, Ismail R, Choon TS, Yoon YK, Wei AC, Pandian S, Kumar RS, Osman H, Manogaran E. Bioorg. Med. Chem. Lett. 2010;20:7064. doi: 10.1016/j.bmcl.2010.09.108. [DOI] [PubMed] [Google Scholar]
- 4b.Girgis AS. Eur. J. Med. Chem. 2009;44:91. doi: 10.1016/j.ejmech.2008.03.013. [DOI] [PubMed] [Google Scholar]
- 4c.Kumar RR, Perumal S, Senthikumar P, Yogeeswari P, Sriram D. J. Med. Chem. 2008;51:5731–5735. doi: 10.1021/jm800545k. [DOI] [PubMed] [Google Scholar]
- 4d.Jiang T, Kuhen KL, Wolff K, Yin H, Bieza K, Caldwell J, Bursulaya B, Wu TY-H, He Y. Bioorg. Med. Chem. Lett. 2006;16:2105–2108. doi: 10.1016/j.bmcl.2006.01.073. [DOI] [PubMed] [Google Scholar]
- 4e.Rottmann M. Science. 2010;329:1175. doi: 10.1126/science.1193225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4f.Periyasami G, Raghunathan R, Surendiran G, Mathivanan N. Bioorg. Med. Chem. Lett. 2008;18:2342. doi: 10.1016/j.bmcl.2008.02.065. [DOI] [PubMed] [Google Scholar]
- 4g.Murugan R, Anbazhagan S, Narayanan SS. Eur. J. Med. Chem. 2009;44:3272. doi: 10.1016/j.ejmech.2009.03.035. [DOI] [PubMed] [Google Scholar]
- 4h.Ranjith Kumar R, Perumal S, Senthilkumar P, Yogeeswari P, Sriram D. Eur. J. Med. Chem. 2009;44:3821. doi: 10.1016/j.ejmech.2009.05.010. [DOI] [PubMed] [Google Scholar]
- 5a.Cao Y, Jiang X, Liu L, Shen F, Zhang F, Wang R. Angew. Chem. 2011;123:9290. doi: 10.1002/anie.201104216. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. Int. Ed. 2011;50:9124. For selected examples of recent years, see: [Google Scholar]
- 5b.Jiang X, Cao Y, Wang Y, Liu L, Shen F, Wang R. J. Am. Chem. Soc. 2010;132:15328. doi: 10.1021/ja106349m. [DOI] [PubMed] [Google Scholar]
- 5c.Wang J, Crane EA, Scheidt KA. Org. Lett. 2011;13:3086. doi: 10.1021/ol200987c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5d.Hande SM, Nakajima M, Kamisaki H, Tsukano C, Takemoto Y. Org. Lett. 2011;13:1828. doi: 10.1021/ol2003447. [DOI] [PubMed] [Google Scholar]
- 5e.Badillo JJ, Arevalo GE, Fettinger JC, Franz AK. Org. Lett. 2011;13:418. doi: 10.1021/ol1027305. [DOI] [PubMed] [Google Scholar]
- 5f.Chen T, Xu X-P, Ji S. J. Comb. Chem. 2010;12:659. doi: 10.1021/cc100064c. [DOI] [PubMed] [Google Scholar]
- 5g.Li Y, Chen H, Shi C, Shi D, Ji S. J. Comb. Chem. 2010;12:231. doi: 10.1021/cc9001185. [DOI] [PubMed] [Google Scholar]
- 5h.Chen H, Shi D. J. Comb. Chem. 2010;12:571. doi: 10.1021/cc100056p. [DOI] [PubMed] [Google Scholar]
- 5i.Shintani R, Hayashi S-y, Murakami M, Takeda M, Hayashi T. Org. Lett. 2009;11:3754. doi: 10.1021/ol901348f. [DOI] [PubMed] [Google Scholar]
- 5j.Liu Y-L, Wang X, Zhao Y-L, Zhu F, Zeng X-P, Cheng L, Wang C-H, Zhao X-L, Zhou J. Angew. Chem. 2013;125:13980. [Google Scholar]
- Angew. Chem. Int. Ed. 2013;52:13735. [Google Scholar]
- 6a.Singh GS, Desta ZY. Chem. Rev. 2012;112:6104. doi: 10.1021/cr300135y. For reviews, see: [DOI] [PubMed] [Google Scholar]
- 6b.Dalpozzo R, Bartoli G, Bencivenni G. Chem. Soc. Rev. 2012;41:7247–7290. doi: 10.1039/c2cs35100e. [DOI] [PubMed] [Google Scholar]
- 6c.Zhou F, Liu Y-L, Zhou J. Adv. Synth. Catal. 2010;352:1381. [Google Scholar]
- 6d.Liu Y, Wang H, Wan J. Asian J. Org. Chem. 2013;2:374. doi: 10.1002/ajoc.201200184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Grigg R, Aly MF, Sridharan V, Thianpatanagul S. J. Chem. Soc. Chem. Commun. 1984:182. [Google Scholar]
- 8.Tsuge O, Kanemasa S, Ohe M, Takenaka S. Bull. Chem. Soc. Jpn. 1987;60:4079. [Google Scholar]
- 9a.Franke A. Justus. Liebigs Ann. Chem. 1978:717. [Google Scholar]
- 9b.Casaschi A, Desimoni G, Faita G, Invernizzi AG, Grünanger P. Heterocycles. 1994;37:1673. [Google Scholar]
- 9c.Aly MF, El-Nagger GM, El-Emary TI, Grigg R, Metwally SAM, Sivagnanam S. Tetrahedron. 1994;50:895. [Google Scholar]
- 9d.Coulter T, Grigg R, Malone JF, Sridharan V. Tetrahedron Lett. 1991;32:5417. [Google Scholar]
- 9e.Ardill H, Grigg R, Sridharan V, Surendrakumar S, Thianpatanagul S, Kanajun S. J. Chem. Soc. Chem. Commun. 1986:602. [Google Scholar]
- 9f.Ardill H, Dorrity MJR, Grigg R, Leon-Ling MS, Malone JF, Sridharan V, Thianpatanagul S. Tetrahedron. 1990;46:6433. [Google Scholar]
- 10a.Bakthadoss M, Sivakumar N, Devaraj A, Sharada DS. Synthesis. 2011:2136–2146. [Google Scholar]
- 10b.Shanmugam P, Viswambharan B, Madhavan S. Org. Lett. 2007;9:4095–4098. doi: 10.1021/ol701533d. [DOI] [PubMed] [Google Scholar]
- 10c.Azizian J, Asadi A, Jadidi K. Synth. Commun. 2001;31:2727–2733. [Google Scholar]
- 10d.Nair V, Sheela KC, Rath NP. Chem. Lett. 2000:980. [Google Scholar]
- 10e.Ghandi M, Taheri A, Abbasi A. Tetrahedron. 2010;66:6744. [Google Scholar]
- 10f.Lakshmi NV, Thirumurugan P, Perumal PT. Tetrahedron Lett. 2010;51:1064. [Google Scholar]
- 10g.Rao JNS, Raghunathan R. Tetrahedron Lett. 2012;53:854. [Google Scholar]
- 10h.Babu ARS, Raghunathan R. Tetrahedron Lett. 2008;49:4618. [Google Scholar]
- 10i.Suresh Babu AR, Raghunathan R. Tetrahedron Lett. 2008;49:4487. [Google Scholar]
- 10j.Suresh Babu AR, Raghunathan R. Tetrahedron Lett. 2007;48:305. [Google Scholar]
- 10k.Jayashankaran J, Maniyan RDRS, Raghunathan R. Tetrahedron Lett. 2004;45:7303. [Google Scholar]
- 10l.Thangamani A. Eur. J. Med. Chem. 2010;45:6120. doi: 10.1016/j.ejmech.2010.09.051. [DOI] [PubMed] [Google Scholar]
- 10m.Suresh Kumar R, Perumal S. Tetrahedron Lett. 2007;48:7164. [Google Scholar]
- 10n.Suresh Kumar R, Rajesh SM, Perumal S, Banerjee D, Yogeeswari P, Sriram D. Eur. J. Med. Chem. 2010;45:411. doi: 10.1016/j.ejmech.2009.09.044. [DOI] [PubMed] [Google Scholar]
- 10o.Liu H, Dou G, Shi D. J. Comb. Chem. 2010;12:292. doi: 10.1021/cc900195t. [DOI] [PubMed] [Google Scholar]
- 10p.Hu X-F, Feng Y-Q. Synth. Commun. 2005;35:1747. [Google Scholar]
- 10q.Lakshmi NV, Thirumurugan P, Jayakumar C, Perumal PT. Synlett. 2010;6:955. [Google Scholar]
- 11a.Rehn A, Bergman J, Stensland B. Eur. J. Org. Chem. 2004:413–418. [Google Scholar]
- 11b.Tan B, Candeias NR, Barbas CF., III Nat. Chem. 2011;3:473. doi: 10.1038/nchem.1039. [DOI] [PubMed] [Google Scholar]
- 11c.Liu J, Sun H, Liu X, Ouyang L, Kang T, Xie Y, Wang X. Tetrahedron Lett. 2012;53:2336–2340. [Google Scholar]
- 11d.Han Y-Y, Chen W-B, Han W-Y, Wu Z-J, Zhang X-M, Yuan W-C. Org. Lett. 2012;14:490. doi: 10.1021/ol203081x. [DOI] [PubMed] [Google Scholar]
- 11e.Cao Y-M, Shen F-F, Zhang F-T, Wang R. Chem. Eur. J. 2013;19:1184. doi: 10.1002/chem.201204114. [DOI] [PubMed] [Google Scholar]
- 11f.Li J, Liu Y, Li C, Jia X. Chem. Eur. J. 2011;17:7409. doi: 10.1002/chem.201100977. [DOI] [PubMed] [Google Scholar]
- 11g.Zhang B, Feng P, Sun L-H, Cui Y, Ye S, Jiao N. Chem. Eur. J. 2012;18:9198. doi: 10.1002/chem.201201375. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary



